FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2296100280> ?p ?o ?g. }

• W2296100280 endingPage "88" @default.
• W2296100280 startingPage "85" @default.
• W2296100280 abstract "Chronic Obstructive Pulmonary Disease (COPD) is a chronic and progressive lung disease characterized by irreversible airflow obstruction, airway inflammation, oxidative stress and, often, mucus hypersecretion. The aim of this study is to determine if carbocisteine, a mucolytic and antioxidant agent, administered daily for 12 months, can reduce exacerbation frequency in COPD patients. This observational study was conducted in Naples (population approximately 1000,000), Italy. It included 85 out-patients (mean age of 67.8 ± 8.6 years) followed by Clinic of Respiratory Diseases of the University Federico II. Every patient underwent spirometry demonstrating airflow obstruction not fully reversible according to ERS/ATS criteria for COPD diagnosis (Tiffenau index less than 70% after administration of salbutamol, a beta2 agonist drug). Patients enrolled had diagnosed COPD since 2 years and suffered at least one exacerbation in the previous year. None of the patients had been treated with carbocisteine or other mucolytic agent for a longer period of time than 7 days and no more than 4 times in the previous year to the enrollment. All of them assumed daily 2.7 g of carbocisteine lysine salt for a year in addition to their basic therapy. The comparison of exacerbation frequency between the previous year (T0) and the end of study treatment (T12), documents a statistically significant reduction of exacerbations(number of exacerbations at T0: 2 [1,3] vs number of exacerbations at T12: 1 [1,2]; p < 0.001).Quality of life was also reported and showed a statistically significant improvement at the end of the study (p < 0.001).We did not find correlation between reducing exacerbation frequency and exposure to cigarette smoking, passive smoking exposure in childhood, the use of inhaled steroids, the level of education of our patients and the GOLD stadium. Daily administration of a mucolytic drug such as carbocisteine for prolonged periods in addition to the bronchodilator therapy can be considered a good strategy for reducing exacerbation frequency in COPD." @default.
• W2296100280 created "2016-06-24" @default.
• W2296100280 creator A5027752847 @default.
• W2296100280 creator A5042139511 @default.
• W2296100280 creator A5049934521 @default.
• W2296100280 creator A5075294017 @default.
• W2296100280 creator A5078100712 @default.
• W2296100280 creator A5087122703 @default.
• W2296100280 creator A5089986005 @default.
• W2296100280 date "2016-04-01" @default.
• W2296100280 modified "2023-10-13" @default.
• W2296100280 title "Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study" @default.
• W2296100280 cites W1968995339 @default.
• W2296100280 cites W2008636933 @default.
• W2296100280 cites W2012519534 @default.
• W2296100280 cites W2026656842 @default.
• W2296100280 cites W2041208066 @default.
• W2296100280 cites W2045749557 @default.
• W2296100280 cites W2093767539 @default.
• W2296100280 cites W2096111866 @default.
• W2296100280 cites W2098115046 @default.
• W2296100280 cites W2112334970 @default.
• W2296100280 cites W2132405655 @default.
• W2296100280 cites W2157968241 @default.
• W2296100280 doi "https://doi.org/10.1016/j.pupt.2016.03.003" @default.
• W2296100280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26970503" @default.
• W2296100280 hasPublicationYear "2016" @default.
• W2296100280 type Work @default.
• W2296100280 sameAs 2296100280 @default.
• W2296100280 citedByCount "6" @default.
• W2296100280 countsByYear W22961002802017 @default.
• W2296100280 countsByYear W22961002802018 @default.
• W2296100280 countsByYear W22961002802019 @default.
• W2296100280 countsByYear W22961002802022 @default.
• W2296100280 countsByYear W22961002802023 @default.
• W2296100280 crossrefType "journal-article" @default.
• W2296100280 hasAuthorship W2296100280A5027752847 @default.
• W2296100280 hasAuthorship W2296100280A5042139511 @default.
• W2296100280 hasAuthorship W2296100280A5049934521 @default.
• W2296100280 hasAuthorship W2296100280A5075294017 @default.
• W2296100280 hasAuthorship W2296100280A5078100712 @default.
• W2296100280 hasAuthorship W2296100280A5087122703 @default.
• W2296100280 hasAuthorship W2296100280A5089986005 @default.
• W2296100280 hasConcept C126322002 @default.
• W2296100280 hasConcept C23131810 @default.
• W2296100280 hasConcept C2776042228 @default.
• W2296100280 hasConcept C2776780178 @default.
• W2296100280 hasConcept C2777014857 @default.
• W2296100280 hasConcept C2777394947 @default.
• W2296100280 hasConcept C2780333948 @default.
• W2296100280 hasConcept C71924100 @default.
• W2296100280 hasConceptScore W2296100280C126322002 @default.
• W2296100280 hasConceptScore W2296100280C23131810 @default.
• W2296100280 hasConceptScore W2296100280C2776042228 @default.
• W2296100280 hasConceptScore W2296100280C2776780178 @default.
• W2296100280 hasConceptScore W2296100280C2777014857 @default.
• W2296100280 hasConceptScore W2296100280C2777394947 @default.
• W2296100280 hasConceptScore W2296100280C2780333948 @default.
• W2296100280 hasConceptScore W2296100280C71924100 @default.
• W2296100280 hasLocation W22961002801 @default.
• W2296100280 hasLocation W22961002802 @default.
• W2296100280 hasOpenAccess W2296100280 @default.
• W2296100280 hasPrimaryLocation W22961002801 @default.
• W2296100280 hasRelatedWork W2059907423 @default.
• W2296100280 hasRelatedWork W2092578503 @default.
• W2296100280 hasRelatedWork W2187186865 @default.
• W2296100280 hasRelatedWork W2410275134 @default.
• W2296100280 hasRelatedWork W2437890223 @default.
• W2296100280 hasRelatedWork W2509081055 @default.
• W2296100280 hasRelatedWork W2951336120 @default.
• W2296100280 hasRelatedWork W3047874532 @default.
• W2296100280 hasRelatedWork W3214931829 @default.
• W2296100280 hasRelatedWork W1895106260 @default.
• W2296100280 hasVolume "37" @default.
• W2296100280 isParatext "false" @default.
• W2296100280 isRetracted "false" @default.
• W2296100280 magId "2296100280" @default.
• W2296100280 workType "article" @default.